GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $36,759,000 | +66.6% | 719,489 | +57.5% | 1.58% | -24.7% |
| Q1 2018 | $22,069,000 | -6.8% | 456,921 | -24.1% | 2.10% | -46.9% |
| Q4 2017 | $23,676,000 | +2797.9% | 601,683 | +2186.9% | 3.95% | +2683.1% |
| Q3 2017 | $817,000 | +13.3% | 26,310 | -0.3% | 0.14% | -6.6% |
| Q2 2017 | $721,000 | -25.3% | 26,377 | +0.7% | 0.15% | -40.2% |
| Q1 2017 | $965,000 | +157.3% | 26,183 | +0.8% | 0.25% | +80.1% |
| Q4 2016 | $375,000 | -83.0% | 25,963 | -72.9% | 0.14% | -78.9% |
| Q3 2016 | $2,206,000 | +36.8% | 95,714 | -1.5% | 0.67% | +21.1% |
| Q2 2016 | $1,612,000 | -46.8% | 97,138 | -49.1% | 0.55% | -49.9% |
| Q1 2016 | $3,029,000 | -46.5% | 190,981 | +9.0% | 1.10% | -41.2% |
| Q4 2015 | $5,663,000 | +45.4% | 175,156 | +89.6% | 1.87% | +54.4% |
| Q3 2015 | $3,896,000 | – | 92,399 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |